The study started in 1990 with 7983 participants of ≥55 years, and it was extended in 2000 to 2001 with 3011 persons. At study entry and every 3 to 4 years, all participants are re-examined at the dedicated research center.
Between 2003 and 2006, all participants who visited the research center for their regular follow-up examination were invited to undergo nonenhanced multidetector computed tomography (CT) to quantify vascular calcification in various vessel beds. 3 In total, we scanned 2524 participants (response rate, 78%).
The Rotterdam Study has been approved by the medical ethics committee according to the Population Screening Act: Rotterdam Study, executed by the Ministry of Health, Welfare and Sports of the Netherlands. All participants provided written informed consent.
Assessment of Atherosclerotic Calcification
Noncontrast CT images were obtained using 16-slice (n=785) or 64-slice (n=1739) multidetector CT scanners (Somatom Sensation 16 or 64; Siemens, Forchheim, Germany). Using a cardiac scan and a scan that reached from the aortic arch to the intracranial vasculature (1 cm above the sella turcica), we scanned the following vessels: coronary arteries, aortic arch, extracranial carotid arteries, and intracranial carotid arteries. The estimated radiation dose was ≤2.1 mSv for the cardiac scan and 2.8 mSv for the extracardiac scan. 9 The field-of-view for both scans was optimized for visualization of blood vessels. Imaging parameters of both scans are described elsewhere. 3 Coronary artery calcification (CAC), aortic arch calcification (AAC), and extracranial carotid artery calcification were quantified using commercially available software (Syngo CalciumScoring; Siemens). 3 We evaluated the left main, left anterior descending, left circumflex, and right coronary arteries. The aortic arch was evaluated from its origin (slice on which the ascending and descending aorta merge into the inner curvature of the arch) to the first centimeter of the common carotid arteries, vertebral arteries, and subclavian arteries beyond the origin of the vertebral arteries. Extracranial carotid artery calcification was measured within 3 cm proximal and distal of the bifurcation. Intracranial carotid artery calcification (ICAC) was evaluated from the horizontal segment of the petrous internal carotid artery to the top (circle of Willis). 10 For ICAC, we used a semiautomated scoring method that is described in detail elsewhere. 10, 11 This method allowed us to manually delineate calcification and calculate the volume by multiplying the number of pixels above the threshold for calcium (ie, 130 Hounsfield units), with the pixel size and slice increment. 10, 11 
Assessment of Mortality
Information on vital status was continuously obtained through automatic linkage of general practitioner files with the study database. Municipal records were checked bimonthly for information on vital status. We gathered information on circumstances and cause of death from general practitioners and hospital records. Research physicians reviewed all information and adjudicated the deaths as described in detail previously. 12 For this study, we categorized deaths as atherosclerotic cardiovascular deaths or noncardiovascular deaths. Atherosclerotic cardiovascular deaths included all deaths from coronary heart disease, intracerebral hemorrhage, cerebral infarction, and atherosclerosis at other locations (ie, ruptured abdominal aortic aneurysms, peripheral vascular disease, and visceral vascular disease). 12 Nonatherosclerotic cardiovascular deaths, such as pulmonary emboli and nonischemic cardiomyopathies, and deaths where the underlying cause could not be determined (n=10) were analyzed as noncardiovascular deaths. 12 Follow-up for mortality and causes of death was complete until January 1, 2012.
Assessment of Cardiovascular Risk Factors
We collected detailed information on cardiovascular risk factors and medication use by interview, physical examination, and blood sampling. 3, 8 Body mass index was calculated as weight (kg) / (height (m)) 2 . Systolic and diastolic blood pressures were measured twice at the right arm, and we used the mean of these measurements in the analyses. Hypertension was defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg, or use of blood pressure-lowering medication. We obtained blood samples in which we measured serum total cholesterol and high-density lipoprotein cholesterol using an automatic enzymatic procedure (Hitachi analyser; Roche Diagnostics). Hypercholesterolemia was defined as total cholesterol concentration ≥6.2 mmol/L or use of lipid-lowering medication. Glucose was determined enzymatically by the Hexokinase method. Diabetes mellitus was defined as fasting serum glucose levels ≥7.0 mmol/L (or nonfasting serum glucose levels ≥11.1 mmol/L if fasting samples were unavailable) or use of antidiabetic therapy.
Smoking status was categorized into current smoker, former smoker, or never smoker. By interview, we assessed information on the use of blood pressure-lowering medication, antidiabetic medication, and lipid-lowering medication. A history of cardiovascular disease at the time of CT was defined as previous stroke, myocardial infarction, or revascularization procedure.
Population for Analysis
A total of 111 CT scans from the 2524 were excluded from the analyses because we were not able to measure calcification volume in at least 1 of 4 vessel beds. Examples include image artifacts because of the presence of pacemakers or coronary stent implantations (65%), bad image acquisition (field-of-view errors or low quality of images; 23%), or intracranial artifacts (eg, intracranial clips; 12%). From the 2413 participants with complete calcification data, we had no followup information on mortality in 5, leaving 2408 persons for the current analyses.
Statistical Analyses
Because calcification volume was a skewed distribution, we used natural log-transformed values and added 1.0 mm 3 to the nontransformed values to deal with calcium volumes of zero (Ln[calcification volume+1.0 mm 3 ]). We assessed the correlation between calcification in the 4 vessel beds using Spearman correlation coefficient.
We created sex-specific quartiles of calcification. Next, we assessed the association of calcification volume (per 1-SD increase and per quartile) in each vessel bed with risk of all-cause, atherosclerotic cardiovascular, and noncardiovascular mortality using Cox regression models. We adjusted these analyses for age and sex (model 1), and additionally for body mass index, systolic and diastolic blood pressures, diabetes mellitus, total cholesterol, high-density lipoprotein cholesterol, use of blood pressure-lowering medication, use of lipid-lowering medication, and smoking (model 2). We also entered all vessel beds simultaneously into 1 model to investigate independent associations, and adjusted for age and sex (model 3).
Next, we used the data augmentation proposed by Lunn and McNeil 13 to be able to directly compare effect estimates of calcification in the different vessel beds on cardiovascular versus noncardiovascular mortality. This allows inference on differences between cause-specific hazard ratios (HRs) of calcification volumes for competing cardiovascular and noncardiovascular death. 14 We repeated abovementioned analyses for calcification volume (per 1-SD increase) and all-cause mortality in separate groups of participants without and with specific cardiovascular risk factors (a history of cardiovascular disease, hypertension, diabetes mellitus, hypercholesterolemia, and current smoking).
We assessed potential effect modification by sex for each vessel bed with each outcome. Moreover, in a sensitivity analysis we investigated potential residual confounding by age by adding a quadratic polynomial term for age to model 1 for analyses on calcification and the 3 mortality outcomes. We also performed a sensitivity analysis with the level of education (as measure of socioeconomic status).
Next, we compared total survival in quartiles of calcification in the 4 separate vessel beds using the Kaplan-Meier method and logrank test.
Finally, we assessed the predictive value of calcification for the mortality outcomes >6-year period. As reference model, we used predictors included in the Pooled Cohort equations as proposed by the American College of Cardiology/American Heart Association. 15 We examined the fit of the new models including calcification using Akaike Information Criterion, and assessed the discriminative ability. 16 To assess calibration, we compared goodness-of-fit of the observed and expected number of events within estimated decile groups. 17 Then, we evaluated the improvement in model performance. Because there are no established risk categories for mortality, we determined continuous net reclassification, 18, 19 and the relative integrated discrimination improvement (ratio of the absolute difference in discrimination slopes of the 2 models over the discrimination slope of the reference model). 20 In 133 (5.5%) participants, ≥1 of the cardiovascular covariates were missing, and they were handled by single imputation with an expectation-maximization algorithm. 21, 22 All analyses were done using IBM SPSS Statistics version 21.0 (IBM Corp, Armonk, NY), R version 3.1.2 (R Foundation for Statistical Computing, Vienna, Austria) with the mstate package, and SAS version 9.3 (SAS Institute Inc, Cary, NC).
Results
The mean age of the study sample was 69.5 years, and 52.4% of the participants were women ( Table 1 ). The prevalence of CAC was 82.1%, 92.6% had AAC, 73.2% had extracranial carotid artery calcification, and 82.0% had ICAC. Table 2 shows the values of sex-specific quartiles of calcification. Correlations between calcification in the different vessel beds are shown in Table I Table 3 shows the associations between calcification in the 4 vessel beds and the risk of mortality. We found that larger calcification volumes in all vessel beds were associated with a higher risk of all-cause mortality, independent of cardiovascular risk factors. After entering all calcification volumes simultaneously in 1 model, AAC remained independently associated with a higher risk of all-cause mortality (HR per 1-SD increase, 1.42 [95% CI, 1.16-1.74]).
Risk of Mortality
Larger calcification volumes in all vessel beds were associated with a higher risk of cardiovascular mortality and noncardiovascular mortality ( Table 4 ). The estimates for calcification volumes on cardiovascular mortality were consistently and significantly higher (P<0.05 for models 1 and 2) than those for noncardiovascular mortality ( Figure 1 demonstrates associations between calcification and all-cause mortality within groups of participants without and with of specific cardiovascular risk factors. We found that especially AAC was related to all-cause mortality in all subgroups.
We found no significant interactions of sex with calcification in any of the vessel beds on any of the outcomes (Table II in the Data Supplement). Sensitivity analyses with a quadratic term for age, or level of education added to the model did not alter the results (data not shown).
Kaplan-Meier curves showed that the overall survival per increasing quartile of calcification became significantly shorter in all the vessel beds ( Figure 2 ).
Predictive Value of Calcification
Addition of calcification in any vessel bed to the reference model improved discrimination for all the 3 mortality outcomes ( Table III in the Data Supplement). Adding calcification at all sites simultaneously provided the best prediction for all-cause, cardiovascular, and noncardiovascular mortality (relative integrated discrimination improvement, 0.10 [95% CI, 0.05-0.16]; 0.30 [95% CI, 0.15-0.48]; and 0.04 [95% CI, 0.00-0.08]). We found no indication for miscalibration in any of the models. Values are mean (SD) for continuous variables or percentages for dichotomous variables. Data represent original data without imputed values. Missing values were present for body mass index (0.8%), blood pressure (0.4%), total cholesterol (1.6%), HDL cholesterol (1.6%), diabetes mellitus (0.1%), lipid-lowering and blood pressure-lowering medication (1.5%), smoking (2.9%), and history of cardiovascular disease (0.4%). HDL indicates high-density lipoprotein.
*Nontransformed median volume with interquartile range.
We additionally investigated the incremental predictive value of AAC over CAC in the reference model. We found a moderate improvement of the predictive value for all the 3 mortality outcomes, which was most prominent for atherosclerotic cardiovascular mortality (c-statistic from 0.81 to 0.82 and continuous net reclassification, 0.36 [95% CI, 0.11-0.57], with a 
Discussion
In this population-based cohort study among elderly persons, we found that the burden of atherosclerosis, as measured by vascular calcification, is associated with an increased risk of death of both cardiovascular and noncardiovascular causes. In particular, aortic arch atherosclerosis was the strongest indicator for both cardiovascular and noncardiovascular mortality, independent of cardiovascular risk factors and calcification elsewhere. Strengths of our study include the population-based setting and the relatively large sample size with standardized image-based measures of calcification in 4 vessels, which allowed head-to-head comparisons within this population. There are also some limitations. First, calcification is only a part of the atherosclerotic plaque. With nonenhanced CT, it is not possible to visualize the complete atherosclerotic plaque area. Strong evidence nonetheless suggests that calcification volume is a suitable measure for the total underlying atherosclerotic burden. 24, 25 Second, besides calcification volume, we had no information on calcium density, which might also be important with regard to subsequent risk of cardiovascular events. 26 Third, participants were relatively old (mean age, 69.5 years), which may limit generalizability of results to younger populations. Moreover, particularly in older individuals calcification of heart valves contributes to cardiovascular mortality, 27, 28 and might be important to consider in future studies on vascular calcification and mortality. Fourth, we used the primary cause of death as defined in medical records of general practitioners and hospitals. Although we applied a rigorous method to discriminate cardiovascular from noncardiovascular death, it is likely that cardiovascular disease may have contributed to noncardiovascular mortality to a certain extent. Finally, it is likely that on average the atherosclerotic burden and death rates will be higher in the general population, than in this study population because of the healthy volunteer effect. 29 Numerous studies have consistently demonstrated the associations of the presence and amount of coronary atherosclerosis with risk of all-cause mortality and cardiovascular mortality. 4, 30, 31 Especially from a population-based perspective, literature on atherosclerosis in other vessel beds and the risk of mortality are sparse, 5 and restricted to coronary and aortic atherosclerosis. There have been studies in specific populations, mainly persons with high cardiovascular risk, demonstrating strong relations between atherosclerosis in the thoracic aorta and higher risk of mortality. 4, 32 A report from the Framingham study also demonstrated a relationship between radiograph-assessed abdominal aortic calcification and a higher risk of mortality. 33 In line with these findings, we found a strong association of aortic arch atherosclerosis with mortality, both cardiovascular and noncardiovascular. Moreover, we showed that AAC relates to a higher risk of mortality even in persons without specific cardiovascular risk factors, including previous cardiovascular disease, which demonstrates its strength as marker for mortality. In fact, it is plausible that given its central location in the arterial system, aortic arch atherosclerosis represents a better reflection of the total burden of atherosclerosis in 1 individual.
Figure 1.
Associations between calcification and all-cause mortality within groups of persons without and with specific cardiovascular risk factors. In total 90.1% had no previous cardiovascular disease (CVD), 25.8% had no hypertension, 51.1% had no hypercholesterolemia, 84.6% did not currently smoke, and 87.5% had no diabetes mellitus. Point estimates represent hazard ratio (HR) with 95% confidence interval (CI; log-scale) per 1-SD increase in calcification volume. Adjusted for age and sex.
When we evaluate our findings against a more clinical background, we found that calcification in any vessel bed improved the prediction of all mortality outcomes, beyond established predictors included in the pooled cohort equations. 15 The clinical relevance and whether a strategy including CT examinations is cost-effective are yet to be explored. 34 However, for CAC this improvement in prediction of cardiovascular outcomes (including mortality) has previously been established, [35] [36] [37] and has become the basis for trials on its use as screening tool for cardiovascular disease. 38 We found that AAC might represent a better reflection an individual's total burden of atherosclerosis, and that it further improved the performance of a prediction model for mortality, which already included CAC. These results can serve as basis for future studies to translate our findings on aortic calcification volume into clinically meaningful risk thresholds. However, the harms and benefits of assessing both CAC and AAC in terms of estimating risk of cardiovascular events should be carefully balanced, especially because this would include an extension of regular CAC-scoring scans with scanning of the aortic arch. Sex differences have been described for relations of CAC and AAC with coronary events. 39 However, for mortality these differences have not been found, 4, 5, 32 and neither did we. Probably, the explanation behind this contrast lies in the definition of coronary events and cardiovascular mortality. The first includes fatal and nonfatal coronary events, whereas the second only includes fatal coronary events and additionally also other fatal cardiovascular events such as stroke, which is a more frequent manifestation of cardiovascular disease in women. 40 An important novelty of our study is that we also studied ICAC as marker of intracranial atherosclerosis. Intracranial atherosclerosis is increasingly considered as an important risk factor for stroke, and as such we studied its contribution to mortality. Although we found ICAC to be associated with higher risks of mortality, the estimates were in general lower than for calcification in the other vessel beds.
We also found associations of atherosclerosis with noncardiovascular mortality; again with the most prominent estimates for aortic arch. We note, however, that although the cause of death may be noncardiovascular (eg, chronic obstructive pulmonary disease or chronic kidney disease), these persons are also more likely to have atherosclerosis. Another explanation for the association between atherosclerosis and noncardiovascular mortality is inflammation. 1, 41, 42 Because chronic inflammation plays a vital role in atherosclerosis, 1 it also contributes significantly to various other chronic diseases such as cancer and dementia 41, 42 ; the two largest contributors to noncardiovascular mortality in this Rotterdam Study data sample.
In summary, we found that atherosclerosis in all vessel beds is associated with an increased risk of death, but the location of atherosclerosis is important with regard to the strength of the associations with mortality. In particular, AAC volume provides unique information with respect to mortality, regardless of atherosclerosis in other vessels.
